George Georges Selected Research

fexofenadine (Allegra)

10/2006	Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
2/2006	Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis.
6/2005	Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
9/2004	Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
10/2003	Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George Georges Research Topics

Disease

10	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2016
10	Allergic Rhinitis 07/2015 - 02/2004
9	Asthma (Bronchial Asthma) 04/2022 - 11/2019
9	Seasonal Allergic Rhinitis (Hay Fever) 07/2015 - 10/2003
3	Sneezing 07/2015 - 09/2004
3	Rhinorrhea 07/2015 - 09/2004
3	Chronic Urticaria 03/2010 - 06/2005
3	Perennial Allergic Rhinitis 04/2009 - 02/2004
2	Pruritus (Itching) 07/2015 - 06/2005
2	Cough 10/2006 - 09/2004
1	Pneumonia (Pneumonitis) 01/2022
1	Obstructive Lung Diseases (Obstructive Lung Disease) 11/2021
1	Systemic Scleroderma (Systemic Sclerosis) 09/2021
1	Multiple Sclerosis 02/2017
1	Disease Progression 02/2017
1	Sleepiness 03/2010
1	Fatigue 03/2010
1	Rhinitis 02/2004
1	Thrombocytopenia (Thrombopenia) 05/2003

Drug/Important Bio-Agent (IBA)

11	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2005
10	Beclomethasone (Beclometasone)FDA Link 04/2022 - 01/2020
9	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2022 - 01/2020
8	Formoterol Fumarate (Oxis)FDA Link 04/2022 - 01/2020
8	Nasal SpraysIBA 07/2015 - 01/2004
8	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2014 - 01/2004
5	Fluticasone (Cutivate)FDA LinkGeneric 01/2022 - 01/2004
5	fexofenadine (Allegra)FDA LinkGeneric 10/2006 - 10/2003
4	Bronchodilator Agents (Bronchodilators)IBA 03/2021 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2022 - 06/2005
3	Muscarinic AntagonistsIBA 01/2021 - 11/2019
3	Histamine Antagonists (Antihistamines)IBA 10/2006 - 09/2004
3	AllergensIBA 10/2006 - 09/2004
2	Cetirizine (Zyrtec)FDA LinkGeneric 07/2015 - 10/2003
2	levocetirizine FDA LinkGeneric 06/2010 - 03/2010
2	trans-sodium crocetinate (crocetin)IBA 10/2006 - 09/2004
2	Pseudoephedrine FDA LinkGeneric 10/2006 - 09/2004
2	Nasal Decongestants (Decongestants)IBA 10/2006 - 09/2004
1	Albuterol (Salbutamol)FDA LinkGeneric 04/2022
1	PropionatesIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2021
1	AerosolsIBA 01/2021
1	lysyl-5-fluorotryptophyl-lysine (Tri (D))IBA 01/2021
1	fluticasone furoate FDA Link 01/2020
1	vilanterolIBA 01/2020
1	GSK573719IBA 01/2020
1	Tiotropium Bromide (Spiriva)FDA Link 11/2019
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 03/2010
1	norflurane (R 134a)IBA 05/2006
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 09/2004
1	Macrophage Colony-Stimulating FactorIBA 05/2003

Therapy/Procedure

10	Nebulizers and Vaporizers (Inhaler) 01/2022 - 01/2016
10	Therapeutics 01/2022 - 01/2019
3	Metered Dose Inhalers (Metered Dose Inhaler) 01/2022 - 01/2021
2	Hematopoietic Stem Cell Transplantation 09/2021 - 02/2017
2	Dry Powder Inhalers 01/2021 - 01/2016
1	Respiratory Therapy (Therapy, Respiratory) 01/2020
1	Transplantation 02/2017